Major Regulatory Milestone in MM: In response to an application by I2TEAMM and IMFmyeloma, the European Medicines Agency has officially endorsed MRD as an early endpoint in clinical trials for Myeloma. This marks a transformative step forward in drug development !! @vincentrk.bsky.social
26.06.2025 04:09 — 👍 3 🔁 2 💬 0 📌 0
📣 We are excited to announce the 10th Heidelberg Myeloma Workshop
Join us on April 25–26, 2025, as international & local experts share the latest advancements in multiple myeloma research.
#mmsm
✅ CME-certified
🔗 Speaker line-up & registration 👇🏼
myelomaworkshop.de
18.04.2025 11:26 — 👍 0 🔁 0 💬 0 📌 0
QS Ranking by Subject: First Place in Life Sciences and Medicine – Heidelberg University takes top positions Germany-wide
www.uni-heidelberg.de/en/newsroom/...
28.03.2025 15:32 — 👍 3 🔁 2 💬 0 📌 0
Prof Martin Kaiser (@mymkaiser.bsky.social) who led the study, says: “We would like all myeloma patients to be able to access the newer diagnostic tests which enable clinicians to group individual patients based on their risk profile and provide treatment that is tailored to their needs.”
19.02.2025 10:04 — 👍 7 🔁 2 💬 1 📌 0
NEW 📰: Research led by ICR scientists and @universityofleeds.bsky.social has shown that #BloodCancer myeloma patients who carry two of more genetic abnormalities – called ‘double hit’ #Myeloma - are at more than twice the risk of their disease progressing early.
19.02.2025 10:04 — 👍 5 🔁 3 💬 1 📌 0
Great teamwork with co-lead Niels Weinhold (@HDMyeloma) and a fantastic effort led by Raphael Lutz, Alexandra Poos, Llorenç Solé Boldo, Lukas John, and many others. Grateful for such an incredible team! 👏 #TeamScience 2/2
08.02.2025 20:38 — 👍 2 🔁 3 💬 0 📌 0
How does multiple myeloma progress? In our latest Science Immunology cover story, we reveal how myeloma cells breaking through bone trigger dangerous diversity. This arises from bidirectional interactions with the immune system, fueling disease evolution. scim.ag/4hMrLHs 1/2
08.02.2025 20:35 — 👍 12 🔁 5 💬 2 📌 0
Die 1386 gegründete Ruperto Carola ist eine der forschungsstärksten in Europa.
I'm interested in the immune response to cancer. Postdoc at Dana-Farber Cancer Institute and Broad Institute, Boston USA. I also like sci-fi literature & electronic dance music. he/him
We are the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. themmrf.org
Hematologist, involved in preclinical and clinical research in plasma cell disorders, MmGTr, EMN, BMSG board, IMWG member, Istinye University Ankara Liv Hospital Türkiye
Haemato-oncologist and myeloma researcher; genetics, imaging and more for patient-centric care. Vice-chair UK NCRI Myeloma Trials. EHA European Affairs. Interested in access and HTA. Academic nomad.
Physician scientist UCLA --> BWH <--> DFCI. Myeloma, CAR-T, CHIP, MDS. LA sports fan stuck in Boston.
Haematologist @ The Christie Hospital and The University of Manchester. Interested in early drug development particularly in Myeloma, AML and MDS
Assistant Professor at Fred Hutch Cancer Center (Seattle, WA, USA) specializing in multiple myeloma #MMsm and CAR-T therapy.
My research focus: improving the patient experience in myeloma.
COI: https://coi.asco.org/share/VU2-FHC3/Rahul%20Banerjee
We're a community dedicated to beating blood cancer- leukaemia, lymphoma, myeloma!
We provide support, information and resources to patients and families affected by blood cancer. If you need help call us on 0808 208 0888.
To cure myeloma by fostering research, education and excellence in clinical care worldwide.
myelomasociety.org
Professor at BIH@Charité, MDC and PHURI@QMUL
Hematologist/Oncologist at the University of Pennsylvania with clinical and research focus on multiple myeloma and related plasma cell disorders.
Myeloma doc/geriatrician/quilter/Wife of Mr Dr Wildes/Mom of Teen/Newly Nebraskan
Embraced imperfection/ditched shame/living in the beautiful truth that we are all Imago Dei
Blood cancer translational scientist with a special love for #myeloma, animals and nature friend | Opinions are my own #MyelomaSky #HemeSky
The American Society of Hematology (ASH) is the world's largest professional society concerned with the causes and treatments of blood disorders. #Hematology #MedSky #BloodSky #HemeSky #HemeOnc
🩸 hematology.org
Not a doctor or scientist;
Spouse dx'ed with MM in 2020;
Hope > hype.
Physician Scientist. Interested in early detection and interception in myeloma.
As quoted in the Manchester Evening News. I hope the fame doesn’t destroy me.
